(Q38760621)

6 September 2017

Oral bioavailability of curcumin: problems and advancements (English)

1 reference

6 September 2017

0 references

1 reference

Weidong Liu

1

1 reference

6 September 2017

Yingjie Zhai

2

1 reference

6 September 2017

Xueyuan Heng

3

1 reference

6 September 2017

Feng Yuan Che

4

1 reference

6 September 2017

Wenjun Chen

5

1 reference

6 September 2017

Dezhong Sun

6

1 reference

6 September 2017

Guangxi Zhai

7

1 reference

6 September 2017

4 March 2016

1 reference

Journal of Drug Targeting

6 September 2017

1 reference

6 September 2017

24

1 reference

6 September 2017

694-702

1 reference

6 September 2017

8

1 reference

Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients

6 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Curcumin: the Indian solid gold

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Curcumin: getting back to the roots.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Dose escalation of a curcuminoid formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Bioavailability of quercetin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Curcumin (diferuloylmethane) delivery methods: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Bioavailability enhancement of curcumin by complexation with phosphatidyl choline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Microemulsion-based media as novel drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Stable drug encapsulation in micelles and microemulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Influence of microemulsions on cutaneous drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Recent advances in curcumin nanoformulation for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Liposomal drug formulations. Rationale for development and what we can expect for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Progress of drug-loaded polymeric micelles into clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Polymeric Micelles as Novel Carriers for Poorly Soluble Drugs--A Review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Polymeric micelles for oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2016.1157883

10.3109/1061186X.2016.1157883

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference